Subtype switching in breast cancer brain metastases: a multicenter analysis

BACKGROUND: Breast cancer (BC) brain metastases (BM) can have discordant hormonal or human epidermal growth factor receptor 2 (HER2) expression compared with corresponding primary tumors. This study aimed to describe incidence, predictors, and survival outcomes of discordant receptors and associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulsbergen, Alexander F C, Claes, An, Kavouridis, Vasileios K, Ansaripour, Ali, Nogarede, Claudine, Hughes, Melissa E, Smith, Timothy R, Brastianos, Priscilla K, Verhoeff, Joost J C, Lin, Nancy U, Broekman, Marike L D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471502/
https://www.ncbi.nlm.nih.gov/pubmed/31970416
http://dx.doi.org/10.1093/neuonc/noaa013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471502/
https://www.ncbi.nlm.nih.gov/pubmed/31970416
http://dx.doi.org/10.1093/neuonc/noaa013

Ejemplares similares